Third European Patent for Biomarker Submitted!

Tuesday, 01 January 2013 More News

After submitting european patents for lysosomal storage deseases in 2011 (Gaucher) and 2012 (NPC) in December last year we submitted another patent for a marker for MLD!

All three markers have remarkably high sensitivity as well as specificity.
pharm-analyt is continuously investigating in biomarkers, predominantly Small Molecules in plasma.

<< back

Did you know:

pharm-analyt has been
GLP certified for almost

30 years.
Our first look might be

invaluable

and it’s for free!
Why our founder’s

hairstyle

sometimes reminds of a well known nuclear physicist? Tell us if you know!
Rumors say:

…For a remarkable bottle of

Chardonnay,

our founder Hermann Mascher would conduct the analysis of a large clinical study for free. :-)
pharm-analyt has developed
multiple ways of

stabilizing peptides

in plasma.
pharm-analyt has discovered biomarkers that will save

the lives of thousands of children

suffering from various rare diseases.
Every day

we are learning something
about bioanalysis.
We are

giving away

a lot of our know-how in Hermann’s book “HPLC Methods for Clinical Pharmaceutical Analysis”.

(See R&D)
50 %

of the analytical know-how lies
in sample preparation.
pharm-analyt requires as little as

50 µL

sample volume for clinical studies,
if necessary.
We are

locals

in the area of trace analysis.
“Edelweiss”

is not the Austrian anthem.
It is our national flower.
In a number of cases chemical

derivatization

might be the key to
success in bioanalysis.
pharm-analyt has won

several awards

for innovation.
We are

always eager
for difficult analytical challenges.
Inpassible…? Imposibol…? Unpossibal…?

Sorry, we’re just not
familiar with this word.
A quote from one of our collaborators concerning PEG tissue analysis: I am totally blown away by the fact that not only do you have measurable levels of PEG

but they are also dose-dependent!!

Amazing stuff!!
pharm-analyt was founded

long before

mass spec was widespread.
"Never give in,
never, never
never, never, in nothing great or small."
(Sir Winston Churchill)
pharm-analyt is

fully family-owned.
pharm-analyt was

one of the first

CROs to switch to electronic archiving.
pharm-analyt has over

100 publications

in peer reviewed journals.
You will get the clinical PK profile of

250

common drugs from us for free.

Contact us.
A part of our historical
premises used to be a

bakery

before we moved in.
pharm-analyt has developed bioanalytical assays for more than

400 compounds.
pharm-analyt conducts

25

(bio)-analytical feasibility
studies each year.
Metabolite profiling is a matter of

a few days,

not months.
We work, where the

Austrian Emperors

went on vacation.

(Historical town of Baden)
pharm-analyt has sold

3 European patents

on biomarkers.
Throughout the

35 years

of pharm-analyt’s existence it
was always equipped with
state-of-the-art instrumentation.
Our most sensitive method has an LLOQ of

0.00000000000025

g/mL plasma.

= 250 femtogram/mL
or 250 x 10^-15 g/mL
or 1 kg sugar in lake Chiemsee!
They say

it’s not feasible?

Give us a try.
Rumors say:

…Of all of our equipment, the
highest throughput is with our

espresso machine?!

›

‹

30 years.

invaluable

hairstyle

Chardonnay,

stabilizing peptides

the lives of thousands of children

Every day

giving away

50 %

50 µL

locals

“Edelweiss”

derivatization

several awards

always eager

Inpassible…? Imposibol…? Unpossibal…?

but they are also dose-dependent!!

long before

never, never

fully family-owned.

one of the first

100 publications

250

bakery

400 compounds.

25

a few days,

Austrian Emperors

3 European patents

35 years

0.00000000000025

it’s not feasible?

espresso machine?!